Experiences of Consumers on the Health Effects of Fake and Adulterated Medicines in Nigeria
Article Sidebar
Main Article Content
Abstract
Medicines are used to cure and treat ailments, relieve or eliminate disease symptoms, and slow down the disease process. Any attempt to disrupt this natural medicine process, using falsified medications, spells doom to a consumer of such medication. The challenge of fake medicines is a global one and affects developing and developed nations and currently assumes great significance as a result of globalization challenges, which have flattened the entire world, hence removing barriers to the movement of products and services. The cross-sectional survey was conducted, using six local government areas of Anambra State in South-East Nigeria, namely Awka, Nnewi, Onitsha, Aguata, Ogbaru, and Anaocha, among adults aged 18 years and above. A minimum sample size of 500 was calculated and stratified sampling was employed to select respondents in order to ensure that various population groups, the upper class, middle class, and lower class were represented.
This research has shown that falsified medicine is an evil wind that blows nobody any good. It negatively affects every aspect of the citizen’s livelihood, ranging from their health, which manifests as treatment failures, deformities, loss of life to death, to loss of confidence in the healthcare providers, revenue losses to individuals, healthcare providers, manufacturers, and finally corruption of the genuine medicines supply chain with fake and adulterated medicines.
The study has clearly shown the experiences of residents of Anambra State, South-East Nigeria with fake and adulterated medicines and also services as a wake-up call to medicines regulators like NAFDAC, PCN, the PSN, and Federal Ministry of Health to declare a state of emergency on the fight against fake and adulterated medicines and make enabling laws that are punitive enough towards the fight against this scourge, so that the healthcare and well-being of Nigerians would be assured at all times.
Article Details
Copyright (c) 2024 Ofomata CM, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Akunyili DN. The War Against Fake Medicines: My Story. Safari Books Ltd. Ibadan. Cambridge House; 2010:19-27.
Akunyili DN. Officials boost fight against counterfeit drugs. Available from: www.scienceafrica.co.za/2007/april/fakedrugs.htm; 2007.
World Health Organization. Combating counterfeit drugs. Available from: https://www.aifa.gov.it/sites/default/files/111.118009.1140600148254b312.pdf; 2006.
Newton PN, Green MD, Fernández FM, Day NP, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006 Sep;6(9):602-13. Available from: https://pubmed.ncbi.nlm.nih.gov/16931411/
Nsimba SE. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy. East Afr J Public Health. 2008 Dec;5(3):205-10. Available from: https://pubmed.ncbi.nlm.nih.gov/19374325/
Hanif M, Mobarak MR, Ronan A, Rahman D, Donovan JJ Jr, Bennish ML. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ. 1995 Jul 8;311(6997):88-91. Available from: https://pubmed.ncbi.nlm.nih.gov/7613408/
Dégardin K, Roggo Y, Margot P. Understanding and fighting the medicine counterfeit market. J Pharm Biomed Anal. 2014 Jan;87:167-75. Available from: https://pubmed.ncbi.nlm.nih.gov/23384475/
Bate R, Ayodele T, Tren R, Hess K, Sotola O. Drug Use in Nigeria. 2009.
All West Africa. West Africa Rallies against Counterfeits. 2010.
International Council of Nurses. Counterfeits Kill; Nurses target counterfeit medicines. Available from: https://www.ordemenfermeiros.pt/arquivo/relacoesinternacionais/Documents/Organizacoes_Internacionais/ICN/Kit_DIE_2005_ing.pdf; 2005.
Ten Ham M. Impact on patients. In: LePark M, editor. Protecting Medicines and Pharmaceuticals: A Manual of Anti-counterfeiting Solutions. Reconnaissance International: Greenwood Village, CO; 2002:21-24. Chapter 4.
Deisingh AK. Pharmaceutical counterfeiting. Analyst. 2005;130:271-279. Available from: https://pubs.rsc.org/en/content/articlelanding/2005/an/b407759h
Polgreen L. 84 Children Are Killed by Medicine in Nigeria. The New York Times. 2009. Available from: https://www.nytimes.com/2009/02/07/world/africa/07nigeria.html
Eboh C. Nigeria Infant drug toll hits 34, antidote flown in. Reuters. 2008.
Harris J, Stevens P, Morris J. Keeping it real: Combating the spread of fake drugs in poor countries. International Policy Network. Available from: https://www.africanliberty.org/wp-content/uploads/Keepingitreal.pdf; 2009.
Mbachu D. Nigeria tainted Syrup Kills 84 Children; drug still selling. Bloomberg.com. 2009 Feb 6. Medine. 2(2).
Milissa McGinnis MA. Matrix of Medicine Quality Reports Affecting USAID assisted Countries by the Promoting the Quality of Medicines program. 2010.
World Health Organization. The quality of Antimalarials: A Study in Seven African Countries. Geneva, Switzerland: World Health Organization; 2003. Available from: https://iris.who.int/handle/10665/68053
Fenoff RS, Wilson JM. African's Counterfeit Pharmaceutical Epidemic: The Road Ahead. 2009. Available from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/africas-counterfeit-pharmaceutical-epidemic-road-ahead
Agege CO. Products and the consumers: An analysis of food and drug legislation in Nigeria. Hein online Food and drug law Journal. 1988;43:201.
Okeke TA, Uzochukwu BS, Okafor HU. An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community. Malar J. 2006;5:97. Available from: https://pubmed.ncbi.nlm.nih.gov/17078875/
Lybecker KM. Rx Roulette: Combating Counterfeit Pharmaceuticals in Developing Nations. Managerial and Decision Economics. 2007;28:509-520. Available from: https://ideas.repec.org/a/wly/mgtdec/v28y2007i4-5p509-520.html
Ofomata CM. Effects of Fake and Adulterated Medicines on Nigerians. A PhD Thesis submitted to the International School of Management (ISM), Paris, France. 2018.
Olike C. The fight against fake drugs by NAFDAC in Nigeria. Paper presented at the 44th International Course in Health Development (ICHD), September 24, 2007―September 12, 2008. KIT (Royal Tropical Institute) Development Policy & Practice/ Vrije Universiteit Amsterdam. Available from: https://www.bibalex.org/Search4Dev/files/353722/193922.pdf
Prazuck T, Falconi I, Morineau G, Bricard-Pacaud V, Lecomte A, Ballereau F PhD. Quality control of antibiotics before the implementation of an STD program in Northern Myanmar. Sex Transm Dis. 2002;29:624-627. Available from: https://journals.lww.com/stdjournal/abstract/2002/11000/quality_control_of_antibiotics_before_the.2.aspx
Erhun WO, Erhun MO, Babalola OO. Drug Regulation and Control in Nigeria: The challenge of counterfeit drugs. J Health Popul Dev Ctries. 2001;4(2):23-34. Available from: https://nairametrics.com/wp-content/uploads/2013/02/Drug_regulation-and-control-in-Nig.pdf
Akunyili DN. Fake and counterfeit drugs in the health sector. Ann Ibadan Postgrad Med. 2004;2:19-23.
Mackey TK, Liang BA. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism. BMC Med. 2013;11:233. Available from: https://pubmed.ncbi.nlm.nih.gov/24228892/
Kron MA. Substandard primaquine phosphate for US Peace Corps personnel. Lancet. 1996;348:1453-1454. Available from: https://pubmed.ncbi.nlm.nih.gov/8937304/
Kao SL, Chan CL, Tan B, Lim CC, Dalan R, Gardner D, et al. . An unusual outbreak of hypoglycemia. N Engl J Med. 2009 Feb 12;360(7):734-6. Available from: https://pubmed.ncbi.nlm.nih.gov/19213693/
Blackstone EA, Fuhr JP Jr, Pociask S. Intellectual property: facts and consumer opinions on counterfeit and pirated goods. American Consumer Institute. 2013 Jul 25. Available from: https://www.theamericanconsumer.org/wp-content/uploads/2013/07/Final-IP-Study-w-Cover.pdf
Liang BA, Mackey TK. Sexual medicine: Online risks to health--the problem of counterfeit drugs. Nat Rev Urol. 2012 Sep;9(9):480-2. Available from: https://pubmed.ncbi.nlm.nih.gov/22824776/
Newton PN, Green MD, Fernández FM. Impact of Poor-Quality Medicines in the 'Developing' World. Trends Pharmacol Sci. 2010;31:99-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20117849.
Akunyili D. Counterfeit and Substandard Drugs, Nigeria’s Experience: Implications, Challenges, Actions And Recommendations. Speech delivered at a meeting for key interest groups on health organized by the World Bank in Washington DC; 2005.
Bate R, Porter K. American Enterprise Institute Health Policy Outlook No. 3: The Problems and Potential of China's Pharmaceutical Industry. Washington, D.C.: American Enterprise Institute; 2009. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2342849
World Health Organization. Counterfeit Medicines. Fact Sheet. 2006. Available from: http://www.who.int/mediacentre/factsheets/fs275/en/.
Newton PN. Murder by Fake Drugs in SE Asia- Prevalence and Prevention. In: Proceedings of the Global Forum on Pharmaceuticals Anti-Counterfeiting; 2002. Geneva, Switzerland: Egham, UK: Reconnaissance International.